<DOC>
	<DOCNO>NCT01776346</DOCNO>
	<brief_summary>The ultimate goal Barrett 's Esophagus Patient Registry help develop effective target screen strategy treatment option Barrett 's esophagus esophageal adenocarcinoma ( EAC ) . We plan develop registry serve platform . Examples analysis could include identify genetic determinant biomarkers predict BE , progression BE EAC , well response therapy .</brief_summary>
	<brief_title>Barrett 's Esophagus Patient Registry</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Barrett 's ( BE ) : Patients Barrett 's esophagus ( stage : Barrett 's metaplasia , lowgrade dysplasia , highgrade dysplasia ) base upon standard endoscopic histologic criterion . Adenocarcinoma ( EAC ) : Patients esophageal adenocarcinoma . The control cohort include patient age 18 old prior history BE EAC . These may include patient see previously see MGH GI Associates condition include gastroesophageal reflux disease , peptic esophagitis , eosinophilic esophagitis , esophageal motility disorder achalasia nutcracker esophagus . Inability unwillingness provide blood sample . History known bleeding disorder . Currently await organ transplantation . Having acute severe chronic illness congestive heart failure condition would prohibit perform endoscopy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>